rs503362
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (C;G) | 0.1 | |
| (G;G) | 0 |
| Make rs503362(C;C) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 11 |
| Position | 101091096 |
| Gene | PGR |
| is a | snp |
| is | mentioned by |
| dbSNP | rs503362 |
| dbSNP (classic) | rs503362 |
| ClinGen | rs503362 |
| ebi | rs503362 |
| HLI | rs503362 |
| Exac | rs503362 |
| Gnomad | rs503362 |
| Varsome | rs503362 |
| LitVar | rs503362 |
| Map | rs503362 |
| PheGenI | rs503362 |
| Biobank | rs503362 |
| 1000 genomes | rs503362 |
| hgdp | rs503362 |
| ensembl | rs503362 |
| geneview | rs503362 |
| scholar | rs503362 |
| rs503362 | |
| pharmgkb | rs503362 |
| gwascentral | rs503362 |
| openSNP | rs503362 |
| 23andMe | rs503362 |
| SNPshot | rs503362 |
| SNPdbe | rs503362 |
| MSV3d | rs503362 |
| GWAS Ctlg | rs503362 |
| GMAF | 0.2135 |
| Max Magnitude | 0.1 |
| ? | (C;C) (C;G) (G;G) | 28 |
|---|---|---|
|
| ||
news The effectiveness of 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth is influenced by SNPs.
Black women
- rs471767 homozygous for the major allele treatment significantly reduced the rate of preterm birth.
- rs578029 who had a least one copy of the major allele, treatment significantly reduced in preterm birth
non-black women
- a least one copy of the minor allele of rs503362 had a significant reduction with treatment
- with at least one copy of the minor allele of rs666553 had a significant reduction in very preterm birth
[PMID 21600550
] Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate
